209 related articles for article (PubMed ID: 3932212)
21. Vaccination of guinea pigs with nutritionally impaired avirulent mutants of Mycobacterium bovis protects against tuberculosis.
De Lisle GW; Wilson T; Collins DM; Buddle BM
Infect Immun; 1999 May; 67(5):2624-6. PubMed ID: 10225931
[TBL] [Abstract][Full Text] [Related]
22. Vaccine-induced cytokine responses in a guinea pig model of pulmonary tuberculosis.
McMurray DN; Allen SS; Jeevan A; Lasco T; Cho H; Skwor T; Yamamoto T; McFarland C; Yoshimura T
Tuberculosis (Edinb); 2005; 85(5-6):295-301. PubMed ID: 16253558
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis.
Williams A; Davies A; Marsh PD; Chambers MA; Hewinson RG
Clin Infect Dis; 2000 Jun; 30 Suppl 3():S299-301. PubMed ID: 10875804
[TBL] [Abstract][Full Text] [Related]
24. A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis.
Horwitz MA; Harth G
Infect Immun; 2003 Apr; 71(4):1672-9. PubMed ID: 12654780
[TBL] [Abstract][Full Text] [Related]
25. Influence of vaccination-challenge interval on the protective efficacy of bacille Calmette-Guérin against low-virulence Mycobacterium tuberculosis.
Edwards ML; Muller D; Smith DW
J Infect Dis; 1981 May; 143(5):739-41. PubMed ID: 6787143
[TBL] [Abstract][Full Text] [Related]
26. Kinetics of the immune response profile in guinea pigs after vaccination with Mycobacterium bovis BCG and infection with Mycobacterium tuberculosis.
Grover A; Taylor J; Troudt J; Keyser A; Arnett K; Izzo L; Rholl D; Izzo A
Infect Immun; 2009 Nov; 77(11):4837-46. PubMed ID: 19737892
[TBL] [Abstract][Full Text] [Related]
27. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
28. Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin.
Chambers MA; Williams A; Gavier-Widén D; Whelan A; Hall G; Marsh PD; Bloom BR; Jacobs WR; Hewinson RG
Infect Immun; 2000 Dec; 68(12):7094-9. PubMed ID: 11083835
[TBL] [Abstract][Full Text] [Related]
29. Host-parasite relationships in experimental airborne tuberculosis. VI. Influence of vaccination with Bacille Calmette-Guérin on the onset and/or extent of hematogenous dissemination of virulent Mycobacterium tuberculosis to the lungs.
Harding GE; Smith DW
J Infect Dis; 1977 Sep; 136(3):439-43. PubMed ID: 409784
[TBL] [Abstract][Full Text] [Related]
30. Mice fed lipid-encapsulated Mycobacterium bovis BCG are protected against aerosol challenge with Mycobacterium tuberculosis.
Aldwell FE; Brandt L; Fitzpatrick C; Orme IM
Infect Immun; 2005 Mar; 73(3):1903-5. PubMed ID: 15731098
[TBL] [Abstract][Full Text] [Related]
31. Mycobacterium bovis Δmce2 double deletion mutant protects cattle against challenge with virulent M. bovis.
Blanco FC; Bianco MV; Garbaccio S; Meikle V; Gravisaco MJ; Montenegro V; Alfonseca E; Singh M; Barandiaran S; Canal A; Vagnoni L; Buddle BM; Bigi F; Cataldi A
Tuberculosis (Edinb); 2013 May; 93(3):363-72. PubMed ID: 23518075
[TBL] [Abstract][Full Text] [Related]
32. Ultraviolet radiation reduces resistance to Mycobacterium tuberculosis infection in BCG-vaccinated guinea pigs.
Jeevan A; Sharma AK; McMurray DN
Tuberculosis (Edinb); 2009 Nov; 89(6):431-8. PubMed ID: 19850524
[TBL] [Abstract][Full Text] [Related]
33. Host-parasite relationships in experimental airborne tuberculosis. I. Preliminary studies in BCG-vaccinated and nonvaccinated animals.
Smith DW; Wiegeshaus E; Navalkar R; Grover AA
J Bacteriol; 1966 Feb; 91(2):718-24. PubMed ID: 4956758
[TBL] [Abstract][Full Text] [Related]
34. Vaccination with recombinant Mycobacterium tuberculosis PknD attenuates bacterial dissemination to the brain in guinea pigs.
Skerry C; Pokkali S; Pinn M; Be NA; Harper J; Karakousis PC; Jain SK
PLoS One; 2013; 8(6):e66310. PubMed ID: 23776655
[TBL] [Abstract][Full Text] [Related]
35. The in vivo immunomodulatory effect of recombinant tumour necrosis factor-alpha in guinea pigs vaccinated with Mycobacterium bovis bacille Calmette-Guérin.
Kramp JC; McMurray DN; Formichella C; Jeevan A
Clin Exp Immunol; 2011 Jul; 165(1):110-20. PubMed ID: 21545584
[TBL] [Abstract][Full Text] [Related]
36. BCG vaccination enhances resistance to M. tuberculosis infection in guinea pigs fed a low casein diet.
Sugawara I; Yamada H; Mizuno S
Tohoku J Exp Med; 2007 Mar; 211(3):259-68. PubMed ID: 17347551
[TBL] [Abstract][Full Text] [Related]
37. Factors influencing the protective efficacy of a BCG homologous prime-boost vaccination regime against tuberculosis.
Griffin JF; Mackintosh CG; Rodgers CR
Vaccine; 2006 Feb; 24(6):835-45. PubMed ID: 16098638
[TBL] [Abstract][Full Text] [Related]
38. Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis.
Aldwell FE; Cross ML; Fitzpatrick CE; Lambeth MR; de Lisle GW; Buddle BM
Vaccine; 2006 Mar; 24(12):2071-8. PubMed ID: 16332403
[TBL] [Abstract][Full Text] [Related]
39. Infection with Mycobacterium avium-intracellulare and the protective effects of Bacille Calmette-Guérin.
Edwards ML; Goodrich JM; Muller D; Pollack A; Ziegler JE; Smith DW
J Infect Dis; 1982 May; 145(5):733-41. PubMed ID: 6804577
[TBL] [Abstract][Full Text] [Related]
40. A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis.
Skinner MA; Buddle BM; Wedlock DN; Keen D; de Lisle GW; Tascon RE; Ferraz JC; Lowrie DB; Cockle PJ; Vordermeier HM; Hewinson RG
Infect Immun; 2003 Sep; 71(9):4901-7. PubMed ID: 12933831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
